Waiting until the end of your cycle to check your blood work is a missed opportunity. By the time a post-cycle panel reveals a problem, that problem has been developing for weeks. Mid-cycle monitoring lets you catch issues while they are still small: and intervene before they become serious.
Think of it like checking your tire pressure during a long road trip rather than waiting for a blowout. A quick check at every rest stop saves you from being stranded on the side of the road. The same logic applies to your body during a cycle.
The analogy holds for blood work because the markers that matter most on a cycle change on different timescales. Hematocrit responds to erythropoietin stimulation within days, blood pressure can shift within a week, and HDL drops noticeably by week 3 or 4. Waiting until week 12 to check these means you have already lost the window for early intervention. Catching a trend early — hematocrit climbing steadily, blood pressure drifting up week over week — gives you and a licensed medical professional room to address it while the options are still simple, rather than discovering it only once the number itself is the emergency. Mid-cycle monitoring is not about reacting to a crisis; it is about seeing the trajectory before it becomes one.
This guide covers the essential checks you should perform during any cycle, with a recommended schedule, specific action thresholds, and practical tips for each marker.
A well-structured monitoring schedule spreads checks across your cycle so nothing is missed. Here is a tested framework based on a 16-week cycle.
Week 4 — Baseline Confirmation
By week 4, your compounds have reached steady state. This is your first real look at how your body is responding. Run a full panel: CBC, comprehensive metabolic panel, lipid panel, estradiol (sensitive), and liver enzymes.
At week 4, the estradiol reading is often the most misunderstood. The assay matters: a standard immunoassay can overestimate estradiol in men compared to a sensitive assay, which is exactly the kind of gap that leads to unnecessary AI use and a crashed estrogen level chasing a number that was never really that high. A high E2 reading paired with real symptoms — water retention, mood swings — is worth bringing to whoever manages your AI or your protocol; it isn't a cue to self-start or escalate a dose. Also check your HDL at week 4: a sharp early drop from baseline is a genuinely useful early signal, and it's worth raising with a licensed medical professional rather than waiting until week 8 to mention it. The week 4 panel is your first chance to have that conversation, not just to collect data.
Compare everything to your pre-cycle baseline. Pay special attention to hematocrit and HDL: these are the markers that move fastest. A sharply falling HDL is worth flagging early rather than waiting to see how low it goes.
Week 8 — Mid-Cycle Checkpoint
This is the most important mid-cycle check. By week 8, all trends are established. Hematocrit should be stable, lipids have reached their cycle bottom, and liver enzymes reflect the full impact of any oral compounds.
Repeat the full panel. Add ApoB if you did not get it at week 4. Check cystatin C for kidney function: creatinine alone will be misleading from training. If anything is trending in the wrong direction, this is a good checkpoint to bring the data to whoever manages your protocol and talk through what, if anything, should change.
ApoB at week 8 gives you a more reliable picture of cardiovascular risk than LDL alone, especially on orals — a meaningfully elevated ApoB is worth flagging for a real conversation, not something to self-manage. Cystatin C is the kidney marker that cuts through the noise. A stable cystatin C with a rising creatinine means your kidneys are handling the load. But if cystatin C is climbing meaningfully from baseline, that's a genuine concern rather than a training artifact, and it's a result to bring to a licensed medical professional promptly — checking hydration and retesting is reasonable first, but the next step from there is theirs to decide, not a dose change you make on your own. The week 8 panel is where you separate real problems from the usual cycle noise.
Week 12 — Final Pre-Post Check
If you are running a 16-week cycle, week 12 is your last real checkpoint before post-cycle blood work. A hematocrit creeping upward, or an HDL that's dropped sharply, are both results worth a prompt conversation with whoever manages your protocol about what changes for the final weeks, rather than something to decide alone from this article.
This panel also serves as your "pre-post" baseline. Having data from week 12 makes your post-cycle recovery panel much more meaningful: you will know exactly where you started coming down from.
The week 12 panel is your last real look before the final weeks of the cycle, and it also sets the stage for your post-cycle recovery. A hematocrit that's elevated at week 12 will generally continue to fall on its own after you stop; if it's slow to come down, donating blood is a safe, direct way to speed that along. The same goes for a suppressed HDL — it typically starts recovering once orals stop, but the pace varies enough between people that planning around a specific number isn't reliable. Use the week 12 numbers as your baseline for the post-cycle panel. The difference between week 12 and post-cycle tells you how much of the shift was reversible, which is exactly what you need to know for your next cycle.
Hematocrit (Ht)
Blood Pressure (BP)
Lipid Panel (HDL, LDL, ApoB)
Liver Enzymes (AST, ALT, GGT)
Knowing your numbers is only half the battle. You also need clear rules for when to take action. Here are the thresholds that separate routine monitoring from active intervention.
These thresholds aren't a self-service treatment ladder — they're a guide to how urgently a result deserves a licensed medical professional's attention, not what to personally do about it. A hematocrit trend matters more than a single value: going from 46% to 50% over four weeks is worth raising before you're anywhere near a commonly cited "action" number, precisely because catching the trajectory early keeps the options simple. The same applies to blood pressure — a single 135/85 reading isn't a crisis, but a pattern consistently above 130/80 for two weeks is worth a real conversation with whoever manages your care, not a self-started medication. The goal is to catch the trend before it becomes a problem, and to bring it to someone who can act on it, not to run the intervention yourself.
- Ht below 50%
- BP below 120/80
- HDL above 30 mg/dL
- AST/ALT below 80 U/L
- Creatinine stable
- Ht 50-54%: mention it at your next check-in
- BP 130-139/85-89: worth a conversation if it holds for 2+ weeks
- HDL 20-30 mg/dL: flag the trend, don't wait for week 12
- AST/ALT 80-200: confirm with GGT before assuming liver stress
- GGT elevated: bring to a licensed medical professional rather than just retesting
- Ht above 57%: prompt medical attention
- BP above 140/90: see a licensed medical professional
- HDL below 15: prompt medical attention
- ALT above 200: prompt medical attention
- eGFR below 60: prompt medical attention
- Hematocrit: every 2-3 weeks
- Blood pressure: daily
- Lipids: every 6-8 weeks
- Liver: at week 4 and 8
- Kidney: at mid-cycle only
Oral AAS and Liver Stress
Oral AAS (methylated compounds like Dianabol, Anadrol, Winstrol, and even Anavar at high doses) are hepatotoxic by design. The 17-alpha-alkylation that makes them orally bioavailable also makes them liver-toxic. This is not a side effect — it is a chemical property of the molecule.
If you are using orals, mid-cycle liver monitoring is not optional. The damage can be silent until it is advanced. Unlike muscle enzyme elevation, which fluctuates with training, liver toxicity is cumulative: it builds up over weeks of exposure.
TUDCA and NAC are commonly used for general liver support, though neither is established to meaningfully offset hepatotoxicity from the compound itself — treat them as a marginal cushion at most, never a reason to run orals longer or ignore your markers.
The key is to know your baseline and your rate of rise. A modest climb in ALT by week 4 is a fairly typical response to an oral; a much sharper rise by week 8 is a faster trajectory than expected and a result to bring to a licensed medical professional rather than adjust the dose yourself — whether that means a lower dose, stopping the oral, or something else is their call, informed by the full picture. Also watch GGT: a rise in GGT with a normal ALT can indicate bile duct issues, a different problem worth its own attention, not something to dismiss just because ALT looks fine. And remember that liver enzymes can be elevated from training too, but the pattern is different: training raises AST more than ALT, and both return to baseline within 48-72 hours. If your ALT is still elevated after a rest day, that points toward the oral rather than the gym.
Kidney Function: Cystatin C Over Creatinine
Mid-cycle creatinine is almost always elevated in athletes: from muscle mass, training (if you trained within 72 hours), and compound effects on renal hemodynamics. It tells you very little about actual kidney function mid-cycle.
If you want a meaningful kidney assessment, request cystatin C. It is unaffected by muscle mass, diet, and training. A stable cystatin C with an elevated creatinine means your kidneys are fine and the creatinine is a training artifact.
The difference between creatinine and cystatin C is like measuring your car's speed with a GPS vs. guessing from the engine noise. One is precise; the other is noisy and unreliable.